FDA
-
-
-
-
-
-
-
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference
-
-
-
-
-
-
-
SeaStar Medical Announces Appointment of Michael Messinger as CFO
-
-
-
-
-
-
-
SeaStar Medical to present pediatric kidney injury therapy data
-
-
-
-
-
-
-
SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)
-
-
-
-
-
-
-
SeaStar Medical raises $4 million in registered direct offering
-
-
-
-
-
-
-
SeaStar Medical (ICU) Provides Update on Nasdaq Listing Status
-
-
-
-
-
-
-
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

